tiprankstipranks
Trending News
More News >
Surgical Science Sweden AB (SE:SUS)
:SUS
Sweden Market

Surgical Science Sweden AB (SUS) Financial Statements

Compare
5 Followers

Surgical Science Sweden AB Financial Overview

Surgical Science Sweden AB's market cap is currently kr1.54B. The company's EPS TTM is kr0.65; its P/E ratio is 24.82; Surgical Science Sweden AB is scheduled to report earnings on February 19, 2026, and the estimated EPS forecast is kr0.36. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuekr 992.34Mkr 884.09Mkr 882.85Mkr 802.54Mkr 366.78M
Gross Profitkr 576.90Mkr 597.90Mkr 612.88Mkr 531.52Mkr 265.94M
Operating Incomekr 108.97Mkr 144.32Mkr 189.15Mkr 162.54Mkr 88.75M
EBITDAkr 192.34Mkr 224.29Mkr 324.53Mkr 271.30Mkr 115.05M
Net Incomekr 66.82Mkr 131.65Mkr 233.97Mkr 187.97Mkr 86.25M
Balance Sheet
Cash & Short-Term Investmentskr 616.42Mkr 968.15Mkr 634.37Mkr 433.73Mkr 316.68M
Total Assetskr 4.69Bkr 5.48Bkr 4.70Bkr 4.65Bkr 3.98B
Total Debtkr 1.63Mkr 292.35Mkr 40.02Mkr 14.68Mkr 12.07M
Net Debtkr -614.80Mkr -675.81Mkr -594.34Mkr -419.05Mkr -304.61M
Total Liabilitieskr 418.31Mkr 651.03Mkr 357.46Mkr 413.11Mkr 393.06M
Stockholders' Equitykr 4.27Bkr 4.83Bkr 4.35Bkr 4.24Bkr 3.59B
Cash Flow
Free Cash Flowkr 68.12Mkr 89.69Mkr 194.16Mkr 94.94Mkr 24.71M
Operating Cash Flowkr 79.80Mkr 137.22Mkr 238.29Mkr 129.49Mkr 39.08M
Investing Cash Flowkr -134.25Mkr -47.53Mkr -44.13Mkr -34.55Mkr -2.73B
Financing Cash Flowkr -259.68Mkr 227.65Mkr 15.85Mkr 17.09Mkr 2.92B
Currency in SEK

Surgical Science Sweden AB Earnings and Revenue History

Surgical Science Sweden AB Debt to Assets

Surgical Science Sweden AB Cash Flow

Surgical Science Sweden AB Forecast EPS vs Actual EPS